RecruitingNCT04535661

Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children

A Retrospective Single Center Study of the Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in PICU Hospitalized Children

Sponsor

Children's Hospital of Fudan University

Enrollment

536 participants

Start Date

Mar 1, 2021

Study Type

OBSERVATIONAL

Conditions

Carbapenem-Resistant Enterobacteriaceae Infection

Summary

Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in China. Pediatric intensive care unit (PICU) is the high-risk area. However, data on the epidemiology of CRE in hospitalized children in PICU are limited. The objectives of this study are to characterize the risk factors for colonization or infection with CRE and describe the microbiologic characteristics of pediatric CRE isolates. The investigators will perform a single retrospective study from January 2018 to December 2019 at PICU of Children's Hospital of Fudan University .

Eligibility

Min Age: 29 DaysMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with carbapenem-resistant enterobacteriaceae infection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 29 Days to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.